Navigation Links
KV Pharmaceutical Reaches Agreement with U.S. Department of Justice
Date:2/25/2010

n the litigation and claims referred to in Note 16 of the Notes to the Consolidated Financial Statements in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and under the heading "Certain Other Matters" in the Company's Form 8-K filed with the SEC on April 30, 2009;  
  • the possibility that the Company's current estimates of the financial effect of certain announced product recalls could prove to be incorrect;
  • whether any product recalls or product introductions result in litigation, agency action or material damages;
  • the satisfaction or waiver of the terms and conditions for the acquisition of the full U.S. and worldwide rights to Gestiva™ set forth in the previously disclosed Gestiva™ acquisition agreement, as amended;
  • the series of putative class action lawsuits alleging violations of the federal securities laws by the Company and certain individuals, all as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8-K filed with the SEC on April 30, 2009, as well as certain other of the Company's SEC filings;
  • the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability or securities litigation;
  • the informal inquiry initiated by the SEC and any related or additional governmental investigative or enforcement proceedings, including actions by the FDA and the U.S. Department of Justice, as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8
    '/>"/>

  • SOURCE KV Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
    (Date:7/22/2014)... , July 22, 2014 Quantum Materials Corporation (OTCQB:QTMM) ... Mr. John Heaton to the Board of Directors. QMC ... Ghassan Jabbour , QMC Chief Science Officer and Board of ... Wong of Rice University and Mr. Tomio Gotoh , ... . " Quantum Materials welcomes two new ...
    (Date:7/21/2014)... -- Champions Oncology (OTC: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year ended April 30, ... The company will host a conference call ... EDT (1:30 p.m. PDT). To participate in the call, ...
    Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
    ... May 5, 2011 IRIDEX Corporation (Nasdaq: IRIX ) ... sales and improved financial results for the first quarter ended April ... $0.06 per diluted share, up from $0.5 million or $0.05 per ... ophthalmology sales grew 10%. Total sales increased to $11.2 million ...
    ... Inc. (Nasdaq: BIOD ) today reported financial results for ... Fiscal Year 2011 Financial Results Biodel reported a net ... million, or $0.21 per share, compared to a net loss of ... the prior year. Research and development expenses were ...
    Cached Medicine Technology:IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 2IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 3IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 4IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 2Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 3Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 4Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 6
    (Date:7/22/2014)... July 22, 2014 For more than ... cold storage consumers with dynamic, specialized humidification ... customer satisfaction. Offering 50-70% less energy requirements than ... This process is completed through a non-chemical procedure ... also provide a 4.2 Micron droplet. The size ...
    (Date:7/22/2014)... Texas (PRWEB) July 22, 2014 For ... Advocate Foundation (PAF) have been working in tandem to ... insurance options, facilitate access to care, and help survivors ... 2014, the two foundations expanded their partnership to include ... by cancer deal with the other practical, emotional, and ...
    (Date:7/22/2014)... Get Real Health announced today a ... (IDF) to provide their patient community with a new ... electronically track their symptoms, medications and other health-related information—enabling ... allow those patients and families who want to ... shared with the U.S. Immunodeficiency Network (USIDNET) registry, ...
    (Date:7/22/2014)... Atreo Services will be presenting its full ... and accessories in booth #1423 at the American Society ... in Chicago, Ill., Aug. 3-6. , Atreo will display ... as well as its selection of liners and inserts ... In addition, representatives will be available to talk ...
    (Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
    Breaking Medicine News(10 mins):Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
    ... -- Women may be less likely to develop premenstrual syndrome ... B vitamins, a new study suggests. Women who ... reduced their risk of PMS, the data suggested. Thiamine ... and researchers said eating two to three servings of thiamine-rich ...
    ... By Jenifer Goodwin HealthDay Reporter , MONDAY, March 14 ... is, a pediatrician or nurse they see regularly who offers comprehensive ... needs met, new research finds. Yet it,s the sickest children ... require the most care -- who are less likely to get ...
    ... for healthier humans around the globe are making headway ... diarrheal illness, according to research from the Frederick S. ... Denver,s (DU) Josef Korbel School of International Studies. ... a series of five volumes that focus on human ...
    ... 14, 2011The first human studies of an oral drug regimen ... near 50% reduction in HIV incidence, but a number of ... be implemented on a large scale, according to an article ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ). ...
    ... Education recently received a five year, $3.7 million grant ... to fund a project aimed at preventing obesity among ... mothers simple yet authoritative strategies to promote appropriate food ... was awarded to Jenifer Orlet Fisher, associate professor of ...
    ... National Institute of Allergy and Infectious Diseases (NIAID), part ... the O157:H7 strain of Escherichia coli causes ... The bacterium secretes a protein called NleH1 that directs ... responses. This process not only helps the bacterium evade ...
    Cached Medicine News:Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 3Health News:DU researchers find that headway being made fighting communicable diseases globally 2Health News:DU researchers find that headway being made fighting communicable diseases globally 3Health News:Early success of anti-HIV preventive oral drug regimen is promising, but questions remain 2Health News:Temple receives $3.7 million to study parenting styles' effect on childhood obesity 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: